TIF
الرئيسية » من نحن » عن الاتحاد الدولي لأنيميا البحر الأبيض المتوسط ’الثلاسيميا’ (TIF) – 2018 » Annual Reports
Latest News:
- FDA grants Orphan Drug Designation for ARU-1801 for the Treatment of Sickle Cell Disease & β-thalassaemia
- Chiesi Group and Apotex Inc. finalize agreement for the acquisition of Ferriprox® (Deferiprone)
- Bluebird bio announces 1st commercial launch of ZYNTEGLO™in Germany
- Deferasirox Accord: A new generic of Exjade recommended for approval by the EMA
- FDA Approves Oxbryta™ (Voxelotor), the First Medicine Specifically Targeting the Root Cause of Sickle Cell Disease
